Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
This guide breaks down scenarios where index funds outperform active funds, highlighting cost savings, tax efficiency, and broad market exposure for beginners.
25,485 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Nokia is quietly positioning itself as a top infrastructure play in AI networking, challenging Cisco's dominance with...
Investors are watching the Fed for its next move, a key factor in whether GLD can extend its recent 36% rally. Real y...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
As BLV pays a steady 4.77% yield, retirees confront a trade-off between dependable income and potential principal swi...
Bitcoin and gold are drifting lower as investors rotate into traditional equities and bonds. Analysts are asking wher...
Former Fed governor Kevin Warsh signals a slower pace for shrinking the Fed's balance sheet, focusing policymakers on...
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
As AI data centers demand more power, nuclear options like NuScale Power and Constellation Energy rise in relevance. ...
Liquid crypto funds have expanded rapidly, but a looming data and workflow gap threatens risk controls as DeFi strate...
Fresh inflows into ripple (xrp) funds continue despite a broad downturn in crypto ETFs. XRP price remains around $1.1...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...